showed a trendp = 0.067
Combination anticancer therapy showed a trend toward higher mortality (33/134, 24.6%) compared with single-modality therapy (64/383, 15.7%; p = 0.067).
Combination anticancer therapy showed a trend toward higher mortality (33/134, 24.6%) compared with single-modality therapy (64/383, 15.7%; p = 0.067).
This difference likewise did not reach statistical significance (p = 0.4288), likely reflecting limited statistical power due to the small number of neutropenic events.